Clinical Trial Update: Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the efficacy of repeated dosing with a high-dose influenza vaccine in patients with gammopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy

Drugs mentioned

• High-dose influenza vaccine

Snippet

Sponsor: Yale University | Conditions: Influenza, Gammopathy | Phase 1 | Status: COMPLETED